Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)

Clinical trial NCT04942080 · RECRUITING

Trial details

NCT number: NCT04942080
Sponsor: University Hospital, Angers
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Myeloproliferative Neoplasm Essential Thrombocythemia Primary Myelofibrosis, Prefibrotic Stage Primary Myelofibrosis, Fibrotic Stage

Start date: 2021-10-28
Primary completion: 2027-04-28
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.